Renfu Pharmaceutical released its report for the first quarter of 2024. During the reporting period, it achieved operating income of 6.367 billion yuan, an increase of 2.28% year on year; net profit attributable to owners of the parent company was 486 million yuan, a decrease of 26.89% year on year.
人福医药：一季度净利润同比减少26.89%
Renfu Pharmaceutical: Net profit for the first quarter decreased by 26.89% year-on-year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated